Vitamin D receptor: No evidence for allele-specific mRNA stability in cells which are heterozygous for the Taq I restriction enzyme polymorphism

被引:90
作者
Verbeek, W
Gombart, AF
Shiohara, M
Campbell, M
Koeffler, HP
机构
[1] Division of Hematology/Oncology, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048, 8700 Beverly Boulevard
关键词
D O I
10.1006/bbrc.1997.7239
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Allelic variations of the vitamin D receptor (VDR) gene have been associated with the risk of developing prostate cancer in men and osteoporosis in postmenopausal women. Three RFLP's (TaqI, ApaI, BsmI) define two common haplotypes: BAt and baT. None of these polymorphisms change the translated protein. Since sequence variations in the 3' UTR of VDR have been linked to the different haplotypes, investigators have proposed that the stability of VDR mRNA is influenced by allelic variations. Indirect evidence suggested that allele T is less stable than allele t. In this study, we used a RT-PCR based approach to compare the stability of the big T and small t allele in normal heterozygous lymphocytes and the heterozygous cell lines NB4 (myeloid leukemia) and PC-3 and DU 145 (prostate cancers). In all three cases, we did net find a significant difference in stability. Interestingly, we consistently observed 30% less RT-PCR product derived from the small t allele mRNA in steady state, a finding which also speaks against a higher stability of the small t allele mRNA. These results indicate a variation in transcriptional regulation rather than mRNA stability between the alleles. We hypothesize that an unknown gene or genes in linkage with the polymorphisms is (are) responsible for the relationship between risk of prostate cancer and VDR polymorphisms. (C) 1997 Academic Press.
引用
收藏
页码:77 / 80
页数:4
相关论文
共 21 条
[1]   STABILIZATION OF THE VITAMIN-D RECEPTOR IN RAT OSTEOSARCOMA CELLS THROUGH THE ACTION OF 1,25-DIHYDROXYVITAMIN-D(3) [J].
ARBOUR, NC ;
PRAHL, JM ;
DELUCA, HF .
MOLECULAR ENDOCRINOLOGY, 1993, 7 (10) :1307-1312
[2]   CLONING AND EXPRESSION OF FULL-LENGTH CDNA-ENCODING HUMAN VITAMIN-D RECEPTOR [J].
BAKER, AR ;
MCDONNELL, DP ;
HUGHES, M ;
CRISP, TM ;
MANGELSDORF, DJ ;
HAUSSLER, MR ;
PIKE, JW ;
SHINE, J ;
OMALLEY, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (10) :3294-3298
[3]   DEGRADATION OF MESSENGER-RNA IN EUKARYOTES [J].
BEELMAN, CA ;
PARKER, R .
CELL, 1995, 81 (02) :179-183
[4]   Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D-3 [J].
Christakos, S ;
RavalPandya, M ;
Wernyj, RP ;
Yang, W .
BIOCHEMICAL JOURNAL, 1996, 316 :361-371
[5]  
CORDER EH, 1993, CANCER EPIDEM BIOMAR, V2, P467
[6]  
EISMANN JA, 1995, J BONE MINER RES, V9, P1289
[7]   ALLELIC VARIATION AND THE VITAMIN-D RECEPTOR [J].
FARROW, S .
LANCET, 1994, 343 (8908) :1242-1242
[8]  
GARNERO P, 1995, J BONE MINER RES, V10, P1283
[9]  
HAUCHETE CL, 1992, CANCER, V70, P2861
[10]   Vitamin D receptor expression is required for growth modulation by 1 alpha,25-dihydroxyvitamin D-3 in the human prostatic carcinoma cell line ALVA-31 [J].
Hedlund, TE ;
Moffatt, KA ;
Miller, GJ .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 58 (03) :277-288